Beneficient filings document the regulatory record for a Nevada financial services company that provides alternative-asset exit opportunities, primary capital solutions, and related trust and custody services. Its disclosures cover Class A common stock, warrants, convertible preferred stock, customized trust vehicles, limited partner interests, and securities issued in primary capital transactions.
The company’s SEC filings include 8-K reports on operating results, unregistered equity issuances, debt agreements and repayments, litigation settlement matters, and other material events. Proxy materials document annual meeting proposals, shareholder voting results, incentive-plan amendments, board and governance matters, while periodic and exhibit disclosures provide additional information on financial condition, risk factors, and capital structure.
Beneficient (BENF) announced the immediate resignation of Brad Heppner from his positions as CEO, Board Chairman, and Director on June 19, 2025. The resignation came after Heppner refused to participate in a formal interview requested by the Audit Committee regarding documents and information concerning his relationship with a related entity provided to auditors in 2019.
Key developments include:
- Heppner rejected proposals to transfer certain rights of Beneficient Holdings Inc (BHI) under a stockholders agreement
- He declined to convert Preferred Series A Subclass 0 Unit Accounts of BCH held by BHI to meet Nasdaq listing requirements
- Through counsel, Heppner expressed belief that "the only viable course for the Company is an orderly wind down of operations"
- Prior to resignation, Heppner served on multiple board committees including Nominating, Community Reinvestment, Executive, Enterprise Risk, and Credit Committees
The stock traded at $0.2770 per share and warrants at $0.0069 as of June 24, 2025. The company remains classified as an emerging growth company and controlled company under Nasdaq rules.
Beneficient (Nasdaq:BENF) filed an 8-K reporting the immediate resignation of CEO & Chairman Brad Heppner on 19-Jun-2025.
The departure followed Heppner’s refusal to participate in a formal Audit Committee interview concerning 2019 related-party documentation. Counsel’s email (Ex. 99.1) shows disagreement with possible voluntary disclosure unless Heppner transferred certain Beneficient Holdings Inc. rights and converted preferred units to strengthen stockholders’ equity for Nasdaq listing compliance.
No successor or severance terms were announced. Heppner also vacates five key board committees, removing leadership over Nominating, Community Reinvestment, Executive, Enterprise Risk and Credit functions.
- Material event: abrupt CEO/Chair resignation
- Governance risk: dispute over audit cooperation and disclosure
- Listing risk: unresolved equity conversion may jeopardize Nasdaq requirements
Beneficient (Nasdaq: BENF) filed Prospectus Supplement No. 16 to update its November 12, 2024 S-1 prospectus with information from a Form 8-K filed on June 25, 2025. The update principally discloses the June 17, 2025 closing of a $1.91 million Series B-8 primary capital transaction conducted through a subsidiary.
Under the agreement, Beneficient’s trust vehicles acquired a limited-partner interest in an investment fund with a net asset value of $1,910,370. In exchange, the customer received 191,037 shares of Series B-8 Resettable Convertible Preferred Stock, each with a $0.001 par value. The preferred shares were issued under Section 4(a)(2) and Regulation D and therefore were not registered under the Securities Act.
The Series B-8 Preferred Stock:
- Initial conversion price: $0.3397 per Class A share, subject to monthly resets but not below 75 % of the initial price and with a floor of $0.2548.
- Maximum share issuance upon conversion: 7,497,528 Class A shares.
- Automatic conversion on the earlier of (i) five years after issuance if reporting or registration conditions are met, or (ii) the first date Rule 144 sales or an effective resale registration become available, all subject to 4.99 % beneficial-ownership and Nasdaq exchange-cap limitations.
- Ranking: pari passu with Class A common; junior to the company’s Series A and Series B-1 through B-7 preferred series.
The company remains an emerging growth and controlled company under Nasdaq rules. As of June 24, 2025, BENF closed at $0.2770; BENFW warrants closed at $0.0069.
Beneficient (NASDAQ:BENF) filed an 8-K announcing the closure of a primary capital transaction through its subsidiary on June 17, 2025. The company issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund valued at $1.91 million.
The Series B-8 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3397 per share, subject to monthly resets and a floor price of $0.2548. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion. The preferred shares rank pari passu with common stock for dividends and liquidation rights.
Beneficient (NASDAQ:BENF) filed an 8-K announcing the closing of a significant equity transaction on June 17, 2025. The company issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in exchange for acquiring a limited partner interest in an investment fund valued at $1.91 million.
The Series B-8 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3397 per share, subject to monthly resets and a floor price of $0.2548. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion. The preferred shares will automatically convert on specific trigger events, including the fifth anniversary of issuance.